COMT Val158Met and BDNF C270T polymorphisms in schizophrenia:: a case-control study

被引:38
作者
Galderisi, S
Maj, M
Kirkpatrick, B
Piccardi, P
Mucci, A
Invernizzi, G
Rossi, A
Pini, S
Vita, A
Cassano, P
Stratta, P
Severino, G
Del Zompo, M
机构
[1] Univ Naples Federico II, Dept Psychiat, SUN, I-80138 Naples, Italy
[2] Univ Maryland, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA
[3] Univ Maryland, Dept Psychiat, Baltimore, MD 21228 USA
[4] Univ Cagliari, Dept Neurosci, Sect Clin Pharmacol, I-09100 Cagliari, Italy
[5] Univ Milan, Dept Psychiat, I-20100 Milan, Italy
[6] Univ Aquila, Dept Psychiat, I-67100 Laquila, Italy
[7] Univ Pisa, Dept Psychiat, I-56100 Pisa, Italy
关键词
catechol-O-methyl transferase gene; brain-derived neurotrophic factor gene; schizophrenia;
D O I
10.1016/j.schres.2004.06.017
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In a multicenter study involving 217 subjects of European ancestry [106 patients with schizophrenia and 111 healthy subjects], we tested the hypothesis that the catechol-O-methyl transferase (COMT) Val(158)Met and/or the brain-derived neurotrophic factor (BDNF) (CT)-T-270 gene polymorphisms are associated with schizophrenia. The COMT and BDNF genotype and their allele distribution did not differ between patients with schizophrenia and healthy comparison subjects. These results do not support the hypothesis that the COMT Val(158)Met or BDNF (CT)-T-270 gene polymorphisms are associated with liability to schizophrenia. (C) 2004 Elsevier B.V All rights reserved.
引用
收藏
页码:27 / 30
页数:4
相关论文
共 12 条
[1]  
DeLisi LE, 2000, AM J MED GENET, V96, P235, DOI 10.1002/(SICI)1096-8628(20000403)96:2<235::AID-AJMG21>3.0.CO
[2]  
2-L
[3]   Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses [J].
Durany, N ;
Michel, T ;
Zöchling, R ;
Boissl, KW ;
Cruz-Sánchez, FF ;
Riederer, P ;
Thome, J .
SCHIZOPHRENIA RESEARCH, 2001, 52 (1-2) :79-86
[4]   Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: A multicenter study [J].
Galderisi, S ;
Maj, M ;
Mucci, A ;
Cassano, GB ;
Invernizzi, G ;
Rossi, A ;
Vita, A ;
Dell'Osso, L ;
Daneluzzo, E ;
Pini, S .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (06) :983-990
[5]   Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia:: Meta-analysis of case-control and family-based studies [J].
Glatt, SJ ;
Faraone, SV ;
Tsuang, MT .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (03) :469-476
[6]   Brain Derived Neurotrophic Factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia [J].
Krebs, MO ;
Guillin, O ;
Bourdel, MC ;
Schwartz, JC ;
Olie, JP ;
Poirier, MF ;
Sokoloff, P .
MOLECULAR PSYCHIATRY, 2000, 5 (05) :558-562
[7]   A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease [J].
Kunugi, H ;
Ueki, A ;
Otsuka, M ;
Isse, K ;
Hirasawa, H ;
Kato, N ;
Nabika, T ;
Kobayashi, S ;
Nanko, S .
MOLECULAR PSYCHIATRY, 2001, 6 (01) :83-86
[8]   Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders [J].
Lachman, HM ;
Papolos, DF ;
Saito, T ;
Yu, YM ;
Szumlanski, CL ;
Weinshilboum, RM .
PHARMACOGENETICS, 1996, 6 (03) :243-250
[9]   A RAPID NONENZYMATIC METHOD FOR THE PREPARATION OF HMW DNA FROM BLOOD FOR RFLP STUDIES [J].
LAHIRI, DK ;
NURNBERGER, JI .
NUCLEIC ACIDS RESEARCH, 1991, 19 (19) :5444-5444
[10]   The molecular genetics of schizophrenia: findings promise new insights [J].
Owen, MJ ;
Williams, NM ;
O'Donovan, MC .
MOLECULAR PSYCHIATRY, 2004, 9 (01) :14-27